Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

NCT04716946 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

NSCLC
Non-small Cell Lung Cancer
Lung Cancer
Non-small Cell Lung Cancer Stage I
Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage III
Non-small Cell Lung Cancer Stage IIIA
PD-L1 Gene Mutation

Interventions

DRUG: Durvalumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]